OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?

Top 3 AI Stocks to Invest in Right Now

Fake shopping sprees and ‘happiness insurance’: The latest fintech apps reveal our financial anxieties

Is Apple’s foldable iPhone Duo worth $2,000? See how it stacks up against other foldable phones.

I gave my HomeExchange guest a 5-star review. Then I found heat marks all over my dining table. Do I call her out?

Inside the push to weaken Washington’s toughest financial watchdog

Scared to spend your retirement money? Here’s one way to get over the fear of running out.

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds

Alphabet to report earnings: AI, ad momentum key to the fourth quarter

February 4, 2026

Wall Street will be looking for more details Google's deal to revamp Apple's Siri virtual assistant with the search company's Gemini AI models. Read more...

Advanced Micro Devices Posts Strong Q4, But Customers Await Actual MI455 Performance, Morgan Stanley Says
Uncategorized

Advanced Micro Devices Posts Strong Q4, But Customers Await Actual MI455 Performance, Morgan Stanley Says

February 4, 2026

Advanced Micro Devices (AMD) posted “overall strong numbers” in Q4, but all eyes are on performance

3rdPartyFeeds

Yum Brands posts mixed quarter, Taco Bell shines

February 4, 2026

Taco Bell's same-store sales spiked 7% in the quarter. Read more...

3rdPartyFeeds

Eli Lilly blows past quarterly estimates, posts strong outlook as Zepbound and Mounjaro sales soar

February 4, 2026

Eli Lilly's full-year guidance comes in stark contrast to the outlook of Novo Nordisk, which warned it sees sales and profit declining as much as 13% this year...

Earnings live: Supermicro, Eli Lilly stocks pop on upbeat forecasts, AMD and Uber slide
Uncategorized

Earnings live: Supermicro, Eli Lilly stocks pop on upbeat forecasts, AMD and Uber slide

February 4, 2026

More Big Tech earnings are ahead from Amazon and Alphabet.

3rdPartyFeeds

Novo Nordisk shares tumble 18% as CEO warns it will get worse before it gets better

February 4, 2026

Just as Novo Nordisk showed signs of a recovery, another cold shower hit investors as the drugmaker surprise prereleased its 2026 forecast late Tuesday...

Tesla’s China-made EV sales rise 9.3% y/y in January
Uncategorized

Tesla’s China-made EV sales rise 9.3% y/y in January

February 4, 2026

BEIJING, Feb 4 () – Tesla sold 69,129 ​China-made electric vehicles ‌in January, up 9.3% ‌from a year earlier, extending gains for a third ⁠consecutive...

Waymo crosses major threshold amid nagging issues
Uncategorized

Waymo crosses major threshold amid nagging issues

February 3, 2026

A private company valued at $1 billion or more used to be so rare that venture capitalists began referring to such firms as “unicorns,” connoting...

Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics
Uncategorized

Eli Lilly Is Getting Into the Hearing Loss Market in a $1.12 Billion Deal With Seamless Therapeutics

February 3, 2026

While riding high on the popularity of its weight loss drug Zepbound, the company is quietly building a presence in a cutting-edge healthcare segment.

3rdPartyFeeds

Why PayPal Stock Crashed Today

February 3, 2026

CEO Alex Chriss is stepping down. Read More...

Previous 1 … 31 32 33 34 35 … 8,455 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.